Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Sep 16; Vol. 23 (1), pp. 343. Date of Electronic Publication: 2024 Sep 16.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Fenofibrate attenuates renal lipotoxicity in uninephrectomized mice with high-fat diet-induced obesity

Authors : Barbara Bruna Abreu Castro; Petrus Ferreira Reno; Bianca Fatima Pereira

Subjects: Lipid Metabolism Disorders; Obesity; Nephrectomy

Source: Brazilian Journal of Nephrology, Vol 46, Iss 4 (2024)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Long-term fenofibrate treatment impaired glucose-stimulated insulin secretion and up-regulated pancreatic NF-kappa B and iNOS expression in monosodium glutamate-induced obese rats: is that a latent disadvantage?

Authors : Liu SN; State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, No,1 Xiannongtan Street, Beijing 100050, PR China.; Liu Q

Subjects: Fenofibrate/Fenofibrate/Fenofibrate/*therapeutic use ; Insulin/Insulin/Insulin/*metabolism ; NF-kappa B/NF-kappa B/NF-kappa B/*metabolism

Source: Journal of translational medicine [J Transl Med] 2011 Oct 14; Vol. 9, pp. 176. Date of Electronic Publication: 2011 Oct 14.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The effect of fenofibrate on the levels of high sensitivity C-reactive protein in dyslipidemic obese patients.

Authors : Coban E; Department of Internal Medicine, Akdeniz University Faculty of Medicine, Antalya, Turkey. ; Sari R

Subjects: C-Reactive Protein/C-Reactive Protein/C-Reactive Protein/*analysis ; Fenofibrate/Fenofibrate/Fenofibrate/*pharmacology ; Hyperlipidemias/Hyperlipidemias/Hyperlipidemias/*blood

Source: Endocrine research [Endocr Res] 2004 Aug; Vol. 30 (3), pp. 343-9.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8408548 Publication Model: Print Cited Medium: Print ISSN: 0743-5800

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Isotretinoin and fenofibrate induce adiposity with distinct effect on metabolic profile in a rat model of the insulin resistance syndrome.

Authors : Sedova L; Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic.; Seda O

Subjects: Insulin Resistance*/Insulin Resistance*/Insulin Resistance*/genetics; Fenofibrate/Fenofibrate/Fenofibrate/*toxicity ; Hypolipidemic Agents/Hypolipidemic Agents/Hypolipidemic Agents/*toxicity

Source: International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9313169 Publication Model: Print Cited Medium: Print NLM ISO Abbreviation:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Short-term Cudrania tricuspidata fruit vinegar administration attenuates obesity in high-fat diet-fed mice by improving fat accumulation and metabolic parameters.

Authors : Choi JH; Department of Food Science and Biotechnology, Gwangju University, Gwangju, 503-703, Republic of Korea.; Kim MK

Subjects: Diet, High-Fat* ; Lipid Metabolism*/Lipid Metabolism*/Lipid Metabolism*/drug effects; Acetic Acid/Acetic Acid/Acetic Acid/*administration & dosage

Source: Scientific reports [Sci Rep] 2020 Dec 03; Vol. 10 (1), pp. 21102. Date of Electronic Publication: 2020 Dec 03.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Fenofibrate enhances lipid deposition via modulating PPARγ, SREBP-1c, and gut microbiota in ob/ob mice fed a high-fat diet

Authors : Ying Zhang; Xiu-Bin Jia; Yun-Chao Liu

Subjects: obesity; NAFLD; triglyceride

Source: Frontiers in Nutrition, Vol 9 (2022)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Saroglitazar is noninferior to fenofibrate in reducing triglyceride levels in hypertriglyceridemic patients in a randomized clinical trial

Authors : Rene Rodriguez-Gutierrez; Jose Gerardo González; Deven Parmar

Subjects: atherosclerosis; lipids; cholesterol/metabolism

Source: Journal of Lipid Research, Vol 63, Iss 7, Pp 100233- (2022)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The Peroxisome Proliferator-Activated Receptor (PPAR) a Agonist Fenofibrate Suppresses Chemically Induced Lung Alveolar Proliferative Lesions in Male Obese Hyperlipidemic Mice.

Authors : Toshiya Kuno^1,2 ; Kazuya Hata² ; Manabu Takamatsu²

Subjects: *PEROXISOME proliferator-activated receptors; *FENOFIBRATE; *PULMONARY alveoli

Source: International Journal of Molecular Sciences. May2014, Vol. 15 Issue 5, p9160-9172. 13p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Relationships of adipocyte-fatty acid binding protein and lipocalin 2 with risk factors and chronic complications in type 2 diabetes and effects of fenofibrate: A fenofibrate Intervention and event lowering in diabetes sub-study

Authors : Ong, KL; Wu, L; Januszewski, AS

Subjects: Heart Disease; Nutrition; Prevention

Source: urn:ISSN:0168-8227 ; urn:ISSN:1872-8227 ; Diabetes Research and Clinical Practice, 169, 108450

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Cardiometabolic benefits of fenofibrate in heart failure related to obesity and diabetes.

Fenofibrate attenuates renal lipotoxicity in uninephrectomized mice with high-fat diet-induced obesity

Long-term fenofibrate treatment impaired glucose-stimulated insulin secretion and up-regulated pancreatic NF-kappa B and iNOS expression in monosodium glutamate-induced obese rats: is that a latent disadvantage?

The effect of fenofibrate on the levels of high sensitivity C-reactive protein in dyslipidemic obese patients.

Isotretinoin and fenofibrate induce adiposity with distinct effect on metabolic profile in a rat model of the insulin resistance syndrome.

Short-term Cudrania tricuspidata fruit vinegar administration attenuates obesity in high-fat diet-fed mice by improving fat accumulation and metabolic parameters.

Fenofibrate enhances lipid deposition via modulating PPARγ, SREBP-1c, and gut microbiota in ob/ob mice fed a high-fat diet

Saroglitazar is noninferior to fenofibrate in reducing triglyceride levels in hypertriglyceridemic patients in a randomized clinical trial

The Peroxisome Proliferator-Activated Receptor (PPAR) a Agonist Fenofibrate Suppresses Chemically Induced Lung Alveolar Proliferative Lesions in Male Obese Hyperlipidemic Mice.

Relationships of adipocyte-fatty acid binding protein and lipocalin 2 with risk factors and chronic complications in type 2 diabetes and effects of fenofibrate: A fenofibrate Intervention and event lowering in diabetes sub-study

اتصل بنا

اتبع